Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 81
Selected: 0
NCT IDTitle
NCT04623814the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
NCT03758287Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
NCT04625361Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC122505MsOH Tablets in Healthy Adult Subjects
NCT05802862A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China
NCT04577703First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid Tumors
NCT04982913Single Dose and Multiple Dose Safety, Tolerability, PK,and Food Effect Study,and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects
NCT04992858Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations
NCT07211165Clinical Study on the Mass Balance of Clifutinib
NCT05397379A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis
NCT05383131To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers
NCT03943251The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects
NCT05057949A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants
NCT05139719A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients
NCT05586074HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
NCT03876925A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC
NCT07102251A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects
NCT04827069A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML)
NCT05395416Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C
NCT05492630Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects
NCT03663686The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects
NCT04147208Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection
NCT05454098Clifutinib Food Effect Study in Healthy Subjects
NCT05497674Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects
NCT04596007The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects
NCT05294536A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects
NCT03125876A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)
NCT03886688HEC53856 Phase 1 Study - Single and Multiple Oral Dosing in Healthy Volunteers
NCT04131192Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer
NCT04194242The Tolerability , Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Adult Subjects
NCT04324372Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors
NCT04202952The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
NCT04551261GLS4/RTV and TAF Drug-drug Interaction
NCT04546984Multiple Dose Safety, Tolerability, PK,PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
NCT04565171Pharmacokinetics of Yimitasvir Phosphate Capsule in Subjects With Normal Renal Function and ESRD
NCT03458481Phase 2 Study of Yimitasvir Phosphate Capsules
NCT07341672A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants
NCT03092102The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
NCT04415853Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
NCT07099118A Safety, Tolerability, Pharmacokinetics/Pharmacodynamics Study of HEC169584 Capsules in Healthy Subjects
NCT05427682A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage
NCT04201275The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects
NCT03888092Z650 in Advanced Esophageal Squamous Cell Carcinoma With EGFR Over Expression or Gene Amplification
NCT03638076The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules
NCT05109078ADME Study of [14C]- Rongliflozin in Healthy Male Subjects
NCT04925661HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia
NCT07082842Confirmatory Clinical Study of HEC585 Tablets in Patients With IPF
NCT05446233ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects
NCT05468346Study on the Body Mass Balance and Biotransformation of [14C]-HEC585
NCT03502902The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects
NCT03462173The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects